European Patent Office

T 3122/19 (FGFR3 fusion gene/CHUGAI SEIYAKU KABUSHIKI) vom 14.09.2023

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2023:T312219.20230914
Datum der Entscheidung
14. September 2023
Aktenzeichen
T 3122/19
Antrag auf Überprüfung von
-
Anmeldenummer
13842962.6
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
FGFR3 fusion gene and pharmaceutical drug targeting same
Name des Antragstellers
Chugai Seiyaku Kabushiki Kaisha
Name des Einsprechenden
Murphy, Colm Damien
Kammer
3.3.04
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 89Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Schlagwörter
Main request - novelty (no)
Auxiliary request 1 - priority, inventive step (no)
Auxiliary request 2 - added matter (no), priority, novelty, inventive step, sufficiency of disclosure (yes)
Late-filed evidence - admitted in first-instance proceedings (no)
Late-filed evidence - should have been submitted in first-instance proceedings (yes)
Amendment after summons - cogent reasons (no)
Orientierungssatz
-
Zitierende Akten
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent in amended form according to the claims of auxiliary request 2, filed as auxiliary request 4 with the patent proprietor's statement setting out the grounds of appeal, and a description and drawings possibly adapted thereto.